miR-340 Inhibits Proliferation and Induces Apoptosis in Gastric Cancer Cell Line SGC-7901, Possibly via the AKT

Jinzhong Yu1, Ruijie Wang2, Jianshe Chen3

  • 1Department of Gastroenterology, Henan Province Hospital of TCM, Zhengzhou, Henan, China (mainland).

Insights

MicroRNA 340 (miR-340) inhibits gastric cancer cell growth and promotes apoptosis. This microRNA may serve as a potential therapeutic target for gastric cancer treatment by regulating the AKT pathway.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Gastric cancer is a leading cause of cancer-related deaths globally.
  • MicroRNAs (miRNAs) are critical regulators in cancer development and progression.
  • Understanding specific miRNA roles, like miR-340, is crucial for gastric cancer research.

Purpose of the Study:

  • To investigate the function of miR-340 in gastric cancer cell proliferation and apoptosis.
  • To elucidate the underlying molecular mechanisms, including pathway involvement.

Main Methods:

  • Human gastric cancer cells (SGC-7901) were transfected with miR-340 mimic or inhibitor.
  • Cell viability, proliferation, and apoptosis were assessed using MTT, BrdU, and flow cytometry.
  • Protein expression of key apoptosis and cell cycle regulators (p27, p21, CASP3, BCL2, BAX, AKT) was analyzed via Western blot.

Main Results:

  • Overexpression of miR-340 significantly decreased SGC-7901 cell viability and proliferation.
  • miR-340 induced apoptosis by increasing cleaved CASP3 and BAX, and decreasing BCL2.
  • miR-340 suppressed AKT phosphorylation and increased p27 levels, while p21 remained unaffected.

Conclusions:

  • miR-340 exhibits tumor-suppressive properties in gastric cancer by inhibiting proliferation and inducing apoptosis.
  • The AKT signaling pathway is implicated in miR-340's mechanism of action.
  • miR-340 presents a promising therapeutic candidate for gastric cancer intervention.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.2K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.0K